Taken together, Trump’s actions will push the average US tariff rate to 15.2 per cent, well above 2024’s 2.3 per cent. Read more at straitstimes.com. Read more at straitstimes.com.

Relay Therapeutics beat analyst estimates for both GAAP revenue and earnings per share in Q2 2025. The company reported continued clinical advancement of its lead asset RLY-2608, with new positive ...

The Burleigh County Commission has approved a preliminary budget that includes a decrease in property taxes due to a buydown ...

Lisata Therapeutics, Inc. (Nasdaq: LSTA) (“Lisata” or the “Company”), a clinical-stage pharmaceutical company developing innovative therapies for the treatment of advanced solid tumors and other ...

The partnership allows Cost Plus Drugs program participants to pick up their prescriptions at the chain's pharmacies.

Health and Human Services Secretary Robert F. Kennedy Jr.'s announcement that the federal government will cancel nearly $500 million in mRNA research funding is unnerving not only for those who ...

As noted in the first article in our Medtech Coming to America series, “US Emerging as Top Global Medtech Destination,” perceived ...

With the new US tariffs imposed by Donald Trump, India will have to pay a 50% import tariff on most of its goods. The ...

How could higher U.S. tariffs on Indian pharmaceutical products impact drug stocks? Seeking Alpha analysts weigh in. Read ...

Pharmexcil Chairman warns US tariffs on Indian pharma will impact global industry, affecting affordable healthcare and ...

Results involving the highest dose of orforglipron disappointed investors — but still bring the drug a step closer to ...

The names of shoplifters sentenced at Northampton Magistrates Court who live in and around the area who have been highlighted ...